BioDelivery Sciences (BDSI) Misses Q4 EPS by 3c
Tweet
Share
E-mailGet Alerts BDSI Hot Sheet
Join SI Premium – FREE
BioDelivery Sciences (NASDAQ: BDSI) reported Q4 EPS of ($0.29), $0.03 worse than the analyst estimate of ($0.26). Revenue for the quarter came in at $3.9 million versus the consensus estimate of $3.88 million.
For earnings history and earnings-related data on BioDelivery Sciences (BDSI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance
- Vislink Technologies Inc. (VISL) Misses Q2 EPS by 7c
- Jasper Therapeutics (JSPR) Tops Q2 EPS by 18c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
